Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vincenzo Ottaviano"'
Autor:
Paola Queirolo, Matteo Lambertini, Virginia Picasso, Francesco Spagnolo, Beatrice Dozin, Vincenzo Ottaviano
Publikováno v:
Cancer Treatment Reviews. 45:38-45
Background The incidence of brain metastases (BM) in melanoma patients is common and associated with poor prognosis. MAP-kinase inhibitors and immunologic checkpoint blockade antibodies led to improved survival of metastatic melanoma patients; howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::597a65cbc5dfe400a318e1aac44d8624
https://doi.org/10.1016/j.ctrv.2016.03.003
https://doi.org/10.1016/j.ctrv.2016.03.003
Autor:
Francesco Spagnolo, Lorenza Pastorino, Elena Tornari, Vincenzo Ottaviano, Paola Queirolo, Virginia Picasso, Paola Ghiorzo, Laura Orgiano
Publikováno v:
OncoTargets and therapy
BRAF inhibitors vemurafenib and dabrafenib achieved improved overall survival over chemotherapy and have been approved for the treatment of BRAF-mutated metastatic melanoma. More recently, the combination of BRAF inhibitor dabrafenib with MEK inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b46b597d02ae9420a404e5851ccf45
http://hdl.handle.net/11567/810084
http://hdl.handle.net/11567/810084
Autor:
Massimo Romani, Antonella Marasco, Paola Queirolo, Maria Pia Pistillo, Vincenzo Ottaviano, Stefania Laurent, Barbara Banelli, Patrizia Piccioli, Beatrice Dozin, Stefano Monteghirfo, Anna Morabito, Paolo A. Ascierto, Massimo Ghio
Publikováno v:
Human immunology. 75(8)
CTLA-4 expression/function can be affected by single nucleotide polymorphisms (SNPs) of CTLA-4 gene, which have been widely associated with susceptibility or progression to autoimmune diseases and cancer development. In this study, we analyzed six CT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf40b69235fa849041dc019485daa22a
https://pubmed.ncbi.nlm.nih.gov/24801647
https://pubmed.ncbi.nlm.nih.gov/24801647
Autor:
Francesco Spagnolo, Paola Queirolo, Virginia Picasso, Elena Tornari, Vincenzo Ottaviano, Paolo Bruzzi, Ester Simeone, Marcello Curvietto, Antonio M. Grimaldi, Paolo A. Ascierto, Domenico Franco Merlo, Laura Giorello
Publikováno v:
Journal of Clinical Oncology. 32:TPS9109-TPS9109
TPS9109 Background: BRAF-inhibitor Vemurafenib achieves high response rate and a statistically significant improvement in overall survival (OS) in patients (pts) with unresectable stage III and IV ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::205e84279a79f93ed0db26a9b847dc69
https://doi.org/10.1200/jco.2014.32.15_suppl.tps9109
https://doi.org/10.1200/jco.2014.32.15_suppl.tps9109
Publikováno v:
Plastic and Reconstructive Surgery. 118:113-114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e3fe1eeb35729204af2c792bfa031df
https://doi.org/10.1097/00006534-200609151-00130
https://doi.org/10.1097/00006534-200609151-00130
Publikováno v:
Plastic and Reconstructive Surgery. 118:150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32dbc290625ab138e69a1068de77eef7
https://doi.org/10.1097/00006534-200609151-00166
https://doi.org/10.1097/00006534-200609151-00166